Home Healthcare Biotechnology Shingles Vaccine Market

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SKYZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Shingles Vaccine Market Size Analysis
    1. Introduction
    2. Shingles Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Shingrix
      2. Zostavax
      3. SKYZoster
    3. Shingles Vaccine Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Recombinant Vaccine
      2. Live Attenuated Vaccine
  7. North America Shingles Vaccine Market Size Analysis
    1. Introduction
    2. Shingles Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Shingrix
      2. Zostavax
      3. SKYZoster
    3. Shingles Vaccine Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Recombinant Vaccine
      2. Live Attenuated Vaccine
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
  8. Europe Shingles Vaccine Market Size Analysis
    1. Introduction
    2. Shingles Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Shingrix
      2. Zostavax
      3. SKYZoster
    3. Shingles Vaccine Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Recombinant Vaccine
      2. Live Attenuated Vaccine
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    6. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
  9. APAC Shingles Vaccine Market Size Analysis
    1. Introduction
    2. Shingles Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Shingrix
      2. Zostavax
      3. SKYZoster
    3. Shingles Vaccine Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Recombinant Vaccine
      2. Live Attenuated Vaccine
    4. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    7. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    9. Singapore
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
  10. Middle East and Africa Shingles Vaccine Market Size Analysis
    1. Introduction
    2. Shingles Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Shingrix
      2. Zostavax
      3. SKYZoster
    3. Shingles Vaccine Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Recombinant Vaccine
      2. Live Attenuated Vaccine
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
  11. LATAM Shingles Vaccine Market Size Analysis
    1. Introduction
    2. Shingles Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Shingrix
      2. Zostavax
      3. SKYZoster
    3. Shingles Vaccine Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Recombinant Vaccine
      2. Live Attenuated Vaccine
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
  12. Competitive Landscape
    1. Shingles Vaccine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Merck & Co., Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. GlaxoSmithKline plc
    3. SK Bioscience
    4. Green Cross Corp
    5. Geneone Life Science
    6. Vaccitech
    7. CanSinoBIO
    8. Cipla Inc.
    9. Pfizer Inc.
    10. Curevo Inc.
    11. SK chemicals
    12. GSK plc
    13. CanSino Biologics Inc
    14. GeneOne Life Science Inc.
    15. Green Cross Corp
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.